Search Results - "Caffrey, Moya V"
-
1
Scaffold-hopping with zwitterionic CCR3 antagonists: Identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092
Published in Bioorganic & medicinal chemistry letters (01-11-2012)“…The discovery and optimisation of a series of zwitterionic CCR3 antagonists is described. Optimisation of the structure led to AZ12436092, a compound with…”
Get full text
Journal Article -
2
Discovery of Potent and Selective Adamantane-Based Small-Molecule P2X7 Receptor Antagonists/Interleukin-1β Inhibitors
Published in Journal of medicinal chemistry (29-11-2007)“…A novel series of antagonists of the human P2X7 receptor is described. Modification of substituents enabled identification of compounds selective for the rat…”
Get full text
Journal Article -
3
Fused mesoionic heterocycles: synthesis of [1,2,3]triazolo[1,5- a]quinoline, [1,2,3]triazolo[1,5- a]quinazoline, [1,2,3]triazolo[1,5- a]quinoxaline and [1,2,3]triazolo[5,1- c]benzotriazine derivatives
Published in Tetrahedron (15-04-2002)“…General methods are descibed for the synthesis of mesoionic derivatives of [1,2,3]triazolo[1,5- a]quinoline, [1,2,3]triazolo[1,5- a]quinazoline,…”
Get full text
Journal Article -
4
Discovery of Potent and Selective Adamantane-Based Small-Molecule P2X 7 Receptor Antagonists/Interleukin-1β Inhibitors
Published in Journal of medicinal chemistry (29-11-2007)Get full text
Journal Article -
5
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors
Published in Journal of medicinal chemistry (29-11-2007)“…A novel series of antagonists of the human P2X7 receptor is described. Modification of substituents enabled identification of compounds selective for the rat…”
Get full text
Journal Article